Skip to main content

Advertisement

SpringerLink
Log in

Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells

  • Correspondence
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S. & Honjo, T. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat. Immunol. 14, 1212–1218 (2013).

    Article  CAS  Google Scholar 

  2. Zhou, F., Qiao, M. & Zhou, C. The cutting-edge progress of immune-checkpoint blockade in lung cancer. Cell. Mol. Immunol. https://doi.org/10.1038/s41423-020-00577-5 (2020).

  3. André, P. et al. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell 175, 1731–1743.e1713 (2018).

    Article  Google Scholar 

  4. Ruf, B., Heinrich, B. & Greten, T. F. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cell. Mol. Immunol. https://doi.org/10.1038/s41423-020-00572-w (2020).

  5. Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450–461 (2015).

    Article  CAS  Google Scholar 

  6. Ohta, A. & Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916–920 (2001).

    Article  CAS  Google Scholar 

  7. Young, A. et al. A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment. Cancer Res. 78, 1003–1016 (2018).

    Article  CAS  Google Scholar 

  8. Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e820 (2019).

    Article  CAS  Google Scholar 

  9. Fishman, P. & Bar-Yehuda, S. Pharmacology and therapeutic applications of A3 receptor subtype. Curr. Top. Med. Chem. 3, 463–469 (2003).

    Article  CAS  Google Scholar 

  10. Willingham, S. B. et al. A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to anti-PD-(L)1 and anti-CTLA-4 in preclinical models. Cancer Immunol. Res. 6, 1136–1149 (2018).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Key R&D Program of China (2020YFA0710802) and the Natural Science Foundation of China (reference number 81872318, 82071768).

Author information

Authors and Affiliations

  1. CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

    Jiacheng Bi & Chaoyue Zheng

  2. Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, 230027, Hefei, China

    Xiaohu Zheng

  3. Institute of Immunology, University of Science and Technology of China, 230027, Hefei, China

    Xiaohu Zheng

Authors
  1. Jiacheng Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chaoyue Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaohu Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaohu Zheng.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bi, J., Zheng, C. & Zheng, X. Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells. Cell Mol Immunol 18, 496–497 (2021). https://doi.org/10.1038/s41423-020-00632-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-020-00632-1

  • Springer Nature Limited

Search

Navigation